Home › Ewing Sarcoma › Tennessee › Nashville
Ewing Sarcoma clinical trials in Nashville, TN
4 studies for Ewing Sarcoma are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
RecruitingPhase 1
- Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville
- Vanderbilt University Medical Center, Nashville
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
RecruitingPhase 1
- Vanderbilt University School of Medicine, Nashville
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
RecruitingPhase 1/2
- Monroe Carrell Jr. Children's Hospital at Vanderbilt, Nashville
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RecruitingPhase 1/2
- Monroe Carrell Jr. Children's Hospital at Vanderbilt, Nashville
Ewing Sarcoma trials in other cities
- New York City, NY8 studies
- Houston, TX7 studies
- Philadelphia, PA7 studies
- Memphis, TN7 studies
- Washington, DC6 studies
- Boston, MA6 studies
- Los Angeles, CA6 studies
- Aurora, CO6 studies
- Atlanta, GA5 studies
- Birmingham, AL5 studies
- Columbus, OH4 studies
- Tampa, FL4 studies
Other studies in Nashville
- Non-Small Cell Lung Cancer97 studies
- Breast Cancer80 studies
- Metastatic Cancer70 studies
- Colorectal Cancer69 studies
- Cancer (all types)65 studies
- Ovarian Cancer49 studies
- Prostate Cancer42 studies
- Lung Cancer40 studies
- Head and Neck Squamous Cell Carcinoma39 studies
- Pancreatic Cancer39 studies
- Endometrial Cancer38 studies
- Melanoma33 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.